Direct effects on bone metabolism induced by perioperative anthracycline- and/or taxane-based chemotherapy depend on the menopausal status of patients with primary breast cancer.

Abstract

1035 Background: Whereas cancer therapy-induced bone loss (CTIBL) is among the well-known sequelae of adjuvant endocrine therapy in patients (pts) with primary breast cancer (PBC), the knowledge ab...